Guardant Health
GH
#1154
Rank
NZ$35.66 B
Marketcap
NZ$263.63
Share price
1.30%
Change (1 day)
56.11%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$6.07

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$6.34. In 2025 the company made an earnings per share (EPS) of NZ-$6.01 an increase over its 2024 EPS that were of NZ-$6.47.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.070.89%
2025NZ-$6.01-7.02%
2024NZ-$6.47-16.82%
2023NZ-$7.77-33.12%
2022NZ-$11.6260%
2021NZ-$7.2755.04%
2020NZ-$4.69207.14%
2019NZ-$1.53-19.81%
2018NZ-$1.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$0.46-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.45-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA